2022-2024 KL2 Career Development Award Program Scholars


Andres Ardisson Korat, ScD
Scientist II, Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA)
Project: Metabolomic Profiles of Cardiovascular Disease and Risk of Frailty in Older Adults

Andres Ardisson Korat, ScD is a Scientist II at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University where his research focuses on nutrition and geriatric syndromes. He earned his ScD in Nutrition and Epidemiology from the Harvard T.H. Chan School of Public Health, an MS in Food Science and Technology from Cornell University, and a BS in Food Industries Engineering from Instituto Tecnologico y de Estudios Superiores in Monterrey (ITESM), Mexico.

The research proposed in this KL2 award aims to investigate our understanding of the intersection of the metabolic factors that lead to the development of both cardiovascular disease and frailty in older adults. Our current knowledge of the biological factors that give rise to frailty is insufficient to inform preventive strategies. Thus, we will use clinical, metabolic, and demographic data from 1,504 Framingham Heart Study Offspring Cohort participants to investigate whether measurements of blood pressure, blood cholesterol and triglyceride levels (cardiovascular risk factors) collected over a period of ~30 years are associated with the development of frailty in adults aged 60 years and older. We will next evaluate whether groupings of these long-term measurements of cardiovascular risk factors are associated with metabolites that predict frailty in older adults. Lastly, we will assess whether specific metabolite patterns explain the relationship between the measured cardiovascular risk factors and the development of frailty using a statistical technique called mediation analysis. The results of this research will help improve our understanding of the role of metabolic patterns in the development of frailty, particularly in the context of patients at high risk for cardiovascular disease, with the aim of identifying targets for future preventive treatments.

Caroline Hsu, MD MS
Neprologist, Tufts Medical Center
Assistant Professor of Medicine, Tufts University School of Medicine
Project: Risk factors for transfer from peritoneal dialysis to hemodialysis

Caroline Hsu is an Assistant Professor of Medicine in the Division of Nephrology at Tufts Medical Center. After earning her BS in Chemical-Biological Engineering and Biology at MIT, she attended medical school at the Icahn School of Medicine at Mount Sinai and completed her Internal Medicine residency at the University of Rochester Medical Center / Strong Memorial Hospital. She joined Tufts Medical Center in 2019 as a Nephrology fellow and is now a member of the Nephrology faculty. Dr. Hsu has developed a research and clinical focus on the care of patients receiving dialysis, with particular interest in peritoneal dialysis. Compared to hemodialysis, peritoneal dialysis has survival and quality of life benefits for many patients. However, due to a variety of incompletely understood reasons, many patients who start peritoneal dialysis experience complications, such as infectious, surgical, or psychosocial complications. These may then lead to discontinuation of peritoneal dialysis, with transition to hemodialysis. Dr. Hsu’s KL2 project will focus on better understanding these risk factors and complications. She is partnering with a mid-size national dialysis provider to examine data from the last 10 years and identify potentially modifiable risk factors. She will also conduct interviews with patients who have undergone the transition from peritoneal dialysis to hemodialysis to better understand their experiences. By identify potential points for intervention, she hopes to ultimately design an intervention to increase retention on peritoneal dialysis and improve care for the individual dialysis patient.

Sushrut Jangi, MD
Gastroenterologist, Tufts Medical Center
Assistant Professor of Medicine, Tufts University School of Medicine
Project: Metagenomic Predictors of Deep Remission in Ulcerative Colitis

Sushrut Jangi, MD is an Assistant Professor of Medicine in the Division of Gastroenterology at Tufts Medical Center. Dr. Jangi completed his residency at Beth Israel Deaconess Medical Center, and Gastroenterology Fellowship at Brigham and Women’s Hospital, with an Inflammatory Bowel Disease Fellowship at University of California, San Diego.

Dr. Jangi’s KL2 project is aimed at understanding why some patients with ulcerative colitis – a form of inflammatory bowel disease – have repeated flares of their illness despite being on therapy. It is known that some patients with ulcerative colitis have very mild disease, meaning they have only a few relapses over the course of their life. Other patients suffer more aggressive disease, leading to frequent relapses, multiple hospitalizations, complications and surgeries.

We still don’t know how to predict who will have mild disease and who will have severe disease. To study this, we are hoping to find clues in a patient’s individual gut microbiome and genetic signatures. By looking at the bacteria living in the gut and the genes in the colon, we can try to put this information together to determine if a patient is at a high risk for having aggressive disease. We think such a personalized approach is invaluable for ultimately empowering patients to understand what kind of disease course they might be facing, and to help their physicians pick treatments that will best treat their disease.


2021-2023 KL2 Career Development Award Program Scholars


Wendy McCallum, MD, MS
Research Fellow, Nephrology, Tufts Medical Center
Project: The Relation of Changes in Kidney Function with Cardiac Hemodynamics and Neurohormonal Activity in Acute Heart Failure

Reduced kidney function is highly prevalent among patients with heart failure, and has been consistently shown to be one of the most powerful risk factors for poor clinical outcomes. Acute declines in kidney function, on the other hand, remain poorly understood, and how they are related to outcomes including longer-term kidney function decline and cardiovascular events is controversial. This study will examine acute kidney function declines and diuretic resistance in the context of invasive cardiac hemodynamics and neurohormonal activity, in order to provide guidance in the management and prognostic interpretation of acute declines in kidney function.

Eric Anderson, PhD
Faculty Scientist I, Maine Medical Center; Assistant Professor, Tufts University School of Medicine
Project: Cancer patients’ expectations for genomic tumor testing

Large-panel genomic tumor testing (GTT) is a promising new technology that offers patients hope for controlling cancer but has limited, uncertain clinical utility for individual patients. Because of the complexity of genomics, many patients struggle to understand GTT, particularly those with limited education. Preliminary research suggests many patients have high expectations of benefitting from GTT, possibly due to glowing media portrayals. It is unknown whether these expectations have beneficial or harmful effects—for example, the mere possibility of GTT might protect patients against hopelessness. On the other hand, unrealistic expectations might lead patients to pursue desperate treatment options that consume precious time and resources at the end-of-life. Little is known about the nature of patients’ expectations or concordance with actual clinical outcomes. Even less is known about expectations in rural, disadvantaged patients who experience a greater cancer burden. The goal of this project is to understand patients’ expectations for GTT and characterize the concordance between these expectations and patients’ actual clinical outcomes. Fostering appropriate knowledge and expectations are critical for translating basic genomic discoveries into practice while minimizing harm. Understanding the effects of geographical and sociodemographic factors will help ensure that the benefits of genomic medicine are equitably distributed.



2020-2022 KL2 Career Development Award Program Scholars


Shanthini Kasturi, MD, MS, Assistant Professor, Tufts University School of Medicine
Project: Integrating PROMIS into SLE Clinical Care

Declining mortality has reframed treatment goals in systemic lupus erythematosus (SLE), but patients and physicians diverge in their prioritization of optimal health outcome goals. While physicians focus on reducing disease activity and SLE-related damage, patients emphasize improving health-related quality of life. Patient-reported outcome measures (PROMs) are powerful tools which can highlight the patient experience of illness, but are not routinely integrated in clinical care. Individuals with SLE are enthusiastic about the potential of PROMs to facilitate patient-centered care, but little is known about the utility and burden of implementing PROMs in SLE clinical encounters. The aim of this proposal is to conduct a pilot study to assess the feasibility and impact of implementing PROMs in the routine clinical care of outpatients with SLE.


Jana Leary, MD, Assistant Clinical Professor, Tufts University School of Medicine
Project: Screening for Social Determinants of Health during Pediatric Hospitalizations: Stakeholder Perspectives and Workflow Implementation

Social determinants of health (SDoH), such as food insecurity and housing instability, are widely acknowledged to have long-lasting effects on health risks and health outcomes. Several screening tools for SDoH have been created and validated in outpatient settings, but patients with social complexity have been shown to have less access to primary care and higher rates of missed outpatient visits, which may preclude screening. Screening for SDoH during pediatric hospitalizations may therefore present a unique opportunity to identify families with unmet social needs that affect child health and health care utilization, but we lack an evidence base on screening for SDoH within inpatient settings. Our study thereby aims to determine the perspectives of key stakeholders (e.g., parents of hospitalized children and pediatric hospital providers) on the best processes for proposed inpatient SDoH screening, to distill these stakeholder perspectives to determine an optimized inpatient screening process, and then to pilot the implementation of this inpatient SDoH screening process within the workflow of one hospital system. This project will inform future proposals to determine effectiveness of the inpatient SDoH screening process within a broader population and to evaluate the impact of inpatient screening paired with social intervention on longer term child health outcomes.


Maya Nadimpalli, MS, PhD, Research Assistant Professor, Tufts University School of Engineering
Project: Identifying Strategies to Improve Gut Resilience to Antibiotic-resistant Pathogens in Lima, Peru

Antimicrobial-resistant (AMR) pathogens are a major public health threat, particularly in lower and middle-income countries where weak public health protections contribute to a high infectious disease burden. Young children in urban informal settlements, often called “shantytowns” or “slums,” are frequently colonized with AMR pathogens like extended-spectrum β-lactamase-producing Escherichia coli (ESBL-Ec) early in life, which increases the risk of transmission and spread of the same organism to non-enteric sites (e.g., sepsis, surgical infections). However, some children in these communities are rarely or never colonized with ESBL-Ec during their first years of life, while others are persistently gut-colonized. Identifying microbial taxa that inhibit children’s gut colonization with ESBL-Ec, as well as early- life exposures that support the assembly and maintenance of these protective taxa, could be helpful in designing future interventions to protect children’s health. The goal of this project is to identify the role of the developing gut microbiome in conferring colonization resistance against ESBL-Ec, and which modifiable early-life factors could help promote this. My long-term goal is to identify behavioral, environmental, and dietary interventions that could protect children from infection with AMR pathogens.


Angie Mae Rodday, PhD, MS, Assistant Professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
Project: Treatment of Hodgkin Lymphoma in Patients Aged ≥65 Years

Dr. Rodday will continue her work on understanding why older patients with Hodgkin lymphoma have worse outcomes than younger patients. Her initial KL2 project used Surveillance, Epidemiology, and End Results (SEER)-Medicare data, which combines information from SEER registries with Medicare claims for patients ≥65 years old. She will now use registry data with more detailed clinical information on patients across the full age spectrum to look differences in treatment and outcomes by age. Her work will continue to explore methods for analyzing observation data.


Marieke Rosenbaum, DVM, MPH, MS, Research Assistant Professor, Cummings School of Veterinary Medicine
Project: The Link between Urban Rodents and Human Health: From Sentinels of Urban Health to Propagators of Disease and Resistance

Urban rat populations are increasing, and rats are known carriers of many diseases that can affect humans, including leptospirosis, hanta virus, and methicillin-resistant Staphylococcus aureus. Through the Tufts CTSI KL2 program I will focus my training and research on understanding how rat populations are distributed throughout the city, what diseases and antimicrobial resistance genes they carry, and how these factors are associated with risk to humans. I plan to combine geospatial analysis with advanced molecular detection techniques and bioinformatics to improve our understanding of the public health risks associated with rats in urban centers and to develop novel insights into strategies to create a healthier environment for all urban dwellers.


2018-2020 KL2 Career Development Award Program Scholars


Adolfo Cuevas, PhD, Assistant Professor, Tufts University School of Arts and Sciences
Project: Psycho-social stress and obesity-related inflammation


Shanthini Kasturi, MD, MS, Assistant Professor, Tufts Medical Center, Rheumatology
Project: Integrating PROMIS into SLE clinical care


Elizabeth (Lila) Peacock-Chambers, MD, MS, Baystate Medical Center, Pediatrics
Project: Integrating a maternal opioid use intervention into Childhood Early Intervention services


Angie Mae Rodday, PhD, MS, Assistant Professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
Project: Treatment of Hodgkin Lymphoma in patients aged ≥65 years


Alysse Wurcel, MD, MS, Tufts Medical Center, Infectious Disease
Project: Delivery of HCV care in jails


2016-2018 KL2 Career Development Award Program Scholars


Alexa Craig, MD, Assistant Professor, Maine Medical Center
Project: Delayed rewarming for neuroprotection in infants following cardiopulmonary bypass surgery: A safety study

Each year 40,000 babies in the United States are born with Congenital Heart Disease (CHD), and one or more surgeries are typically required during the first year of life to correct their heart defects. While overall survival has improved, developmental outcomes remain suboptimal, given that 20% of infants classified with simple CHD and 50% of those with complex CHD experience significant developmental delay. My long-term goal is to improve developmental outcomes for infants with CHD through the identification and modulation of factors that adversely impact the brain and subsequently disrupt development.


Keren Ladin, PhD, MSc, Assistant Professor, Tufts University School of Arts and Sciences
Project: Mitigating disparities in shared decision-making and end-of-life care among African-Americans with kidney failure

The Decision-Aid for Renal Therapy (DART) is an interactive web-based decision-aid that can empower patients and caregivers to select the modality that best suits them. Although proven effective and in current use in the general population, DART’s effectiveness in an older population is unclear. The purpose of this project is to tailor and conduct a pilot study of DART’s feasibility and effectiveness to improve end-of-life planning and shared decision-making among older end-stage renal disease patients.


Teresa May, DO, Assistant Professor, Maine Medical Center
Project: Variation in sedation and neuromuscular blockade practices on outcomes after cardiac arrest

Targeted temperature management (TTM) is an established method of providing neuroprotection for survivors of cardiac arrest. During temperature management, sedation and neuromuscular
blockade (NMB) are needed to manage the physiologic state of lower body temperature, but there is significant variability in selection and application of this management. The lack of focused research connecting sedation and NMB to neurological outcomes means that sedation protocols vary widely among centers and that guidelines have not yet been able to address these aspects of care.

Most cardiac arrest registries focus on the pre-hospital and emergency department setting; one exception is the International Cardiac Arrest Registry (INTCAR), an American and European registry. This large dataset represents an opportunity to identify variability in sedation and NMB practices between centers, and evaluate their influence on functional and cognitive outcome. However, the current database does not have patient-level data on strategies for sedation and NMB use and lacks some important sedation-related outcomes, although these data can be collected prospectively at several of the larger centers. Collecting prospective data provides the opportunity to perform patient-level observational comparative effectiveness analysis of these different strategies and potentially offer individualized treatment regimens.


2014-2016 KL2 Career Development Award Program Scholars


Robert Blanton, MD, Assistant Professor of Medicine, Tufts Molecular Cardiology Research Institute
Project: Identification of Heart-Specific Anti-remodeling Molecules
Our laboratory seeks to identify new therapeutic targets for the syndrome of heart failure, a major cause of death in the U.S. We and others have found in pre-clinical models that a molecule called Protein Kinase G I (PKG) inhibits the structural changes in the left ventricle which lead to heart failure. However, drugs which activate PKG have been studied in humans with heart failure but have not yet improved clinical outcomes. The current project attempts to translate the basic findings on PKG into improved therapeutic strategies for heart failure. First, in basic laboratory studies we will try to understand how exactly PKGI cooperates with other molecules in the heart to inhibit cardiac remodeling, since understanding these cooperating molecules might reveal new therapeutic targets. Second, we will undertake the first study to date of PKG in heart tissue from humans with a specific type of heart failure, called nonischemic cardiomyopathy. We hope that understanding the regulation of PKG in the human heart will reveal new therapeutic strategies for patients with heart failure.


Deborah Linder, DVM, DACVN, Research Assistant Professor, Tufts University Cummings School of Veterinary Medicine

Project: Promoting Children’s Physical Activity with Pets
Pediatric obesity is a serious and growing public health concern, with significant physical and mental health consequences on youth that suffer from obesity. Unfortunately, the development of effective and sustainable obesity treatment interventions remains a challenge. Pets can potentially provide physical and psychosocial health benefits to improve impact and sustainability of obesity interventions. Our proposed study will test the hypothesis that incorporating pet dogs into a comprehensive behavioral intervention will significantly increase sustained physical and psychosocial factors in overweight and obese children. By testing the effectiveness of integrating human-animal interaction into a comprehensive obesity intervention, we hope to gain important knowledge on how to potentially improve and expand successful and cost effective obesity interventions to reduce the rate of the childhood obesity.


Quinn R. Pack, MD, MSc, Medical Director of Cardiac Rehabilitation, Baystate Medical Center; Assistant Professor of Medicine, Tufts University School of Medicine
Project: Phase I Cardiac Rehabilitation and Hospital Outcomes
Inpatient cardiac rehabilitation assists hospitalized patients with cardiac disease begin to understand their disease, regain their strength, and improve their lifestyle to help prevent future heart problems. In this study, Dr. Pack will be studying the effects of inpatient cardiac rehabilitation on hospital readmission rates, hospital discharge placement to a nursing home vs. home, and the incidence of deep venous thrombosis and pulmonary embolism. We will utilize the PREMIER database of more than 350 hospitals and adjust all outcomes for patient risk and hospital characteristics. We anticipate demonstrating that inpatient cardiac rehabilitation improves patient and hospital outcomes.